Waverley Pharma Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CAD 0.382721 million compared to CAD 0.353305 million a year ago. Net loss was CAD 0.207248 million compared to net income of CAD 0.000989 million a year ago. For the nine months, sales was CAD 1.29 million compared to CAD 0.949521 million a year ago. Net loss was CAD 0.528473 million compared to CAD 0.383609 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.